--- title: "Global Business Travel Group Posts Upbeat Q1 Results, Joins Cabaletta Bio, Aura Biosciences And Other Big Stocks Moving Higher On Monday" type: "News" locale: "en" url: "https://longbridge.com/en/news/285084393.md" description: "Global Business Travel Group Inc (GBTG) saw its stock surge 57% to $9.31 after reporting Q1 earnings of 10 cents per share, exceeding estimates. The company also reported sales of $840 million, surpassing expectations. Other notable gainers included Cabaletta Bio Inc (+14.1%), Celcuity Inc (+13.4%), and Aura Biosciences Inc (+12.6%). Despite mixed performance in U.S. stocks, several companies recorded significant gains on Monday." datetime: "2026-05-04T13:54:15.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/285084393.md) - [en](https://longbridge.com/en/news/285084393.md) - [zh-HK](https://longbridge.com/zh-HK/news/285084393.md) --- # Global Business Travel Group Posts Upbeat Q1 Results, Joins Cabaletta Bio, Aura Biosciences And Other Big Stocks Moving Higher On Monday U.S. stocks were mixed, with the Dow Jones index falling around 200 points on Monday. Shares of **Global Business Travel Group Inc** (NYSE:GBTG) rose sharply during Monday's session after the company reported better-than-expected first-quarter financial results. Global Business Travel reported quarterly earnings of 10 cents per share which beat the analyst consensus estimate of 7 cents per share. The company reported quarterly sales of $840.000 million which beat the analyst consensus estimate of $815.976 million. Global Business Travel shares jumped 57% to $9.31 on Monday. Here are some other big stocks recording gains in today’s session. - **Cabaletta Bio Inc** (NASDAQ:CABA) jumped 14.1% to $3.36. The company announced the pricing of its $150 million offering of 51.73 million shares at $2.90 per share. - **Celcuity Inc** (NASDAQ:CELC) gained 13.4% to $142.52 after the company announced topline results from the PIK3CA mutant cohort of the Phase 3 VIKTORIA-1 clinical trial. The company met its primary endpoint. - **Aura Biosciences Inc** (NASDAQ:AURA) surged 12.6% to $7.89. Aura Biosciences announced pricing of $260 million public offering of common stock and pre-funded warrants. - **Cullinan Therapeutics Inc** (NASDAQ:CGEM) gained 12.6% to $15.12. BTIG analyst Julian Harrison reiterated Cullinan Therapeutics with a Buy and maintained a $38 price target. - **Xerox Holdings Corp** (NASDAQ:XRX) rose 12.2% to $3.03. - **Axsome Therapeutics In**c (NASDAQ:AXSM) gained 11.6% to $230.49 after the company reported a wider first-quarter loss that missed Wall Street estimates, overshadowing stronger-than-expected revenue. - **Nebius Group NV** (NASDAQ:NBIS) gained 10.7% to $171.12. On Friday, the company disclosed it is strengthening its position with the acquisition of Eigen AI. - **L B Foster Co** (NASDAQ:FSTR) shares jumped 10.7% to $34.00 following first-quarter results. - **Circle Internet Group Inc** (NYSE:CRCL) gained 9.7% to $109.44. - **IREN Ltd** (NASDAQ:IREN) surged 9.4% to $49.97. - **BlackBerry Ltd** (NYSE:BB) gained 9.3% to $5.94. - **Lightwave Logic Inc** (NASDAQ:LWLG) rose 9% to $17.74. - **Nice Ltd** (NASDAQ:NICE) gained 8.6% to $122.67. - **Micron Technology Inc** (NASDAQ:MU) jumped 7.3% to $582.07. Micron CEO Sanjay Mehrotra recently highlighted during a CNBC interview that the expansion of AI inference is increasing demand for tokens that require faster, higher-capacity memory. - **Maxlinear Inc** (NASDAQ:MXL) gained 6% to $81.80. _Photo via Shutterstock_ ### Related Stocks - [CELC.US](https://longbridge.com/en/quote/CELC.US.md) - [GBTG.US](https://longbridge.com/en/quote/GBTG.US.md) - [AURA.US](https://longbridge.com/en/quote/AURA.US.md) - [CABA.US](https://longbridge.com/en/quote/CABA.US.md) - [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md) - [CGEM.US](https://longbridge.com/en/quote/CGEM.US.md) - [XRX.US](https://longbridge.com/en/quote/XRX.US.md) - [AXSM.US](https://longbridge.com/en/quote/AXSM.US.md) - [NBIS.US](https://longbridge.com/en/quote/NBIS.US.md) - [FSTR.US](https://longbridge.com/en/quote/FSTR.US.md) - [CRCL.US](https://longbridge.com/en/quote/CRCL.US.md) - [IREN.US](https://longbridge.com/en/quote/IREN.US.md) - [BB.US](https://longbridge.com/en/quote/BB.US.md) - [LWLG.US](https://longbridge.com/en/quote/LWLG.US.md) - [NICE.US](https://longbridge.com/en/quote/NICE.US.md) - [MU.US](https://longbridge.com/en/quote/MU.US.md) - [MXL.US](https://longbridge.com/en/quote/MXL.US.md) - [XRXDW.US](https://longbridge.com/en/quote/XRXDW.US.md) ## Related News & Research - [Aura Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | AURA Stock News](https://longbridge.com/en/news/286966217.md) - [Aura Biosciences Highlights Bel-Sar Eye Cancer Strategy, Mid-Year Bladder Data](https://longbridge.com/en/news/286990060.md) - [VALION BIO BRIEFS SENIOR DEPARTMENT OF WAR AND BARDA OFFICIALS IN JOINT ENGAGEMENT ON ENTOLIMOD FOR ACUTE RADIATION SYNDROME | VBIO Stock News](https://longbridge.com/en/news/286964504.md) - [Matrix Capital Management Comp Sells 6,922,870 Shares of Aura Biosciences (NASDAQ:AURA) Stock](https://longbridge.com/en/news/286058101.md) - [Kyntra Bio Rocked by CEO’s Sudden Insider Stock Sale](https://longbridge.com/en/news/286847501.md)